VANI Stock Analysis: Buy, Sell, or Hold?
VANI - Vivani Medical, Inc. Common Stock (DE)
$1.17
-0.02 (-1.68%)
▼
5d:
+0.0%
30d:
-2.5%
90d:
+4.46%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When VANI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VANI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VANI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VANI is currently trading at $1.17, which is considered fair relative to its 30-day fair value range of $1.13 to $1.26.
Technical Outlook: Technically, VANI is in a downtrend. Immediate support is located at $1.13, while resistance sits at $1.33.
Market Sentiment: VANI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.75 (+215.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VANI is in a downtrend. Immediate support is located at $1.13, while resistance sits at $1.33.
Market Sentiment: VANI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.75 (+215.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.13 -
$1.26
Company Quality Score
50/100
(HOLD)
Options IV Signal
31th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
54.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 31th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 215.1% below Wall St target ($3.75)
Trading Range Analysis
30-Day Trading Range
$1.13 -
$1.26
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.20
(17.4%)
Support & Resistance Levels
Support Level
$1.13
Resistance Level
$1.33
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.97
Wall Street Target
$3.75
(+215.1%)
Share & Embed Analysis
Last updated: June 24, 2026 1:06 PM ET
Data refreshes hourly during market hours. Next update: 2:06 PM
Data refreshes hourly during market hours. Next update: 2:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VANI showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Gregg Williams
BUY
1587301 shares
2026-04-15
Gregg Williams
BUY
1575231 shares
2026-03-15
Gregg Williams
BUY
1351351 shares
2026-01-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 64 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 65 BUY |
